Ying Jing

Title: Ying Jing: Innovator in Transfection Reagents and Viral Vector Production

Introduction

Ying Jing is a notable inventor based in Reinach, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing transfection reagents and enhancing viral vector yields. With a total of 2 patents, his work has the potential to impact various applications in genetic engineering and therapeutic development.

Latest Patents

Ying Jing's latest patents include a scalable method for producing transfection reagents. This invention provides easy-to-scale methods of creating DNA/transfection reagent master mixes for transfecting cells in culture. Another significant patent involves the use of tonicifying agents to enhance recombinant adeno-associated virus yield. This invention outlines methods for the production of recombinant adeno-associated virus vectors (rAAV), which includes culturing producer cells in media with increased osmolality. Additionally, it provides methods for decreasing the production of helper virus by a rAAV producer cell.

Career Highlights

Ying Jing is currently employed at Ultragenyx Pharmaceutical Inc., where he continues to innovate in the field of biotechnology. His work focuses on developing advanced methods that can improve the efficiency and effectiveness of gene therapy techniques.

Collaborations

Ying Jing collaborates with Jan Panteli, contributing to the advancement of their shared goals in the biotechnology sector.

Conclusion

Ying Jing's contributions to the field of biotechnology through his patents and work at Ultragenyx Pharmaceutical Inc. highlight his role as an influential inventor. His innovative methods for producing transfection reagents and enhancing viral vector yields are paving the way for advancements in genetic engineering and therapeutic applications.